IFNA1 and infection: As with wild-type SINV, the maximal titer of the D355A mutant steadily increased as the addition of type I IFN was delayed to later times postinfection; however, the relative differences in titer between the IFN-treated infections and nontreated control indicate that the D355A mutant was significantly more resistant to the impacts of type I IFN overall.